Estimating Demand for Potential Disease modifying Therapies for Alzheimer’s Disease in the UK
View ORCID ProfileAxel AS Laurell, View ORCID ProfileAshwin V Venkataraman, Tatjana Schmidt, Marcella Montagnese, Christoph Mueller, Robert Stewart, Jonathan Lewis, Clare Mundell, Jeremy D Isaacs, Mani S Krishnan, Robert Barber, View ORCID ProfileTimothy Rittman, Benjamin R Underwood
doi: https://doi.org/10.1101/2023.11.17.23298682
Axel AS Laurell
1Department of Psychiatry, University of Cambridge, Cambridge, UK
2Cambridgeshire and Peterborough NHS Foundation Trust, UK
Ashwin V Venkataraman
3Department of Old Age Psychiatry, IoPPN, King’s College London, London, UK
4Centre for Neuroimaging Sciences, IoPPN, King’s College London, London, UK
5South London and Maudsley NHS Foundation Trust, London, UK
Tatjana Schmidt
6Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
Marcella Montagnese
6Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
Christoph Mueller
3Department of Old Age Psychiatry, IoPPN, King’s College London, London, UK
5South London and Maudsley NHS Foundation Trust, London, UK
Robert Stewart
3Department of Old Age Psychiatry, IoPPN, King’s College London, London, UK
5South London and Maudsley NHS Foundation Trust, London, UK
Jonathan Lewis
2Cambridgeshire and Peterborough NHS Foundation Trust, UK
Clare Mundell
2Cambridgeshire and Peterborough NHS Foundation Trust, UK
Jeremy D Isaacs
7Department of Neurology, Atkinson Morley Regional Neuroscience Centre, St George’s University Hospitals NHS Foundation Trust, London
8Molecular and Clinical Sciences Research Institute, St George’s, University of London, London
Mani S Krishnan
9Tees, Esk and Wear Valleys NHS Foundation Trust, UK
Robert Barber
10Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
Timothy Rittman
6Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
Benjamin R Underwood
1Department of Psychiatry, University of Cambridge, Cambridge, UK
2Cambridgeshire and Peterborough NHS Foundation Trust, UK
Article usage
Posted November 17, 2023.
Estimating Demand for Potential Disease modifying Therapies for Alzheimer’s Disease in the UK
Axel AS Laurell, Ashwin V Venkataraman, Tatjana Schmidt, Marcella Montagnese, Christoph Mueller, Robert Stewart, Jonathan Lewis, Clare Mundell, Jeremy D Isaacs, Mani S Krishnan, Robert Barber, Timothy Rittman, Benjamin R Underwood
medRxiv 2023.11.17.23298682; doi: https://doi.org/10.1101/2023.11.17.23298682
Estimating Demand for Potential Disease modifying Therapies for Alzheimer’s Disease in the UK
Axel AS Laurell, Ashwin V Venkataraman, Tatjana Schmidt, Marcella Montagnese, Christoph Mueller, Robert Stewart, Jonathan Lewis, Clare Mundell, Jeremy D Isaacs, Mani S Krishnan, Robert Barber, Timothy Rittman, Benjamin R Underwood
medRxiv 2023.11.17.23298682; doi: https://doi.org/10.1101/2023.11.17.23298682
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12634)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4494)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2876)
- Health Policy (1059)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4264)
- Nursing (228)
- Nutrition (626)
- Oncology (2232)
- Ophthalmology (637)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6845)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)